Canaan Partners

After raising $62M, New Haven biotech Allyx Therapeutics advances experimental Alzheimer’s drug

The New Haven biotech, a Yale spinout, has raised $60 million to test an oral Alzheimer's therapy that takes a different approach than recently approved treatments.

Get our email newsletters

Stay up-to-date on the companies, people and issues that impact businesses in Hartford and beyond.

Latest Stories

🔒Developers buy Enfield mill site, launch 156-unit apartment project

Avangrid splits CFO role between two executives as finance...

Mass. trucking company revives plans for Manchester hub

Popular Mystic tourist sailing ship business for sale

More Business News

Movers & Shakers

Dimeo Construction Co. Welcomes Blakely S. Dimeo as Business Development Manager

Jon Scavone Joins Titan Energy as their Director, Sustainability Services

Marysa Santos Joins CBIZ as Managing Director in Hartford

Community Housing Advocates CEO Receives Homelessness Social Justice Award

More Movers & Shakers | Submit an Announcement

Thought Leadership

Building a Business That Outlasts You: Best Practices for...

Politics & Policy Forum: The Business of Energy

40 Under Forty 2026 Awards

Canaan Partners

Latest Stories

🔒Developers buy Enfield mill site, launch 156-unit apartment project

Avangrid splits CFO role between two executives as finance...

Mass. trucking company revives plans for Manchester hub

Popular Mystic tourist sailing ship business for sale

Movers & Shakers

Dimeo Construction Co. Welcomes Blakely S. Dimeo as Business Development Manager

Jon Scavone Joins Titan Energy as their Director, Sustainability Services

Marysa Santos Joins CBIZ as Managing Director in Hartford

Community Housing Advocates CEO Receives Homelessness Social Justice Award

Thought Leadership

Building a Business That Outlasts You: Best Practices for...

From Customer Service Representative to Plant President

Career Opportunities

Upcoming Events

About

Subscribe

Follow HBJ